Method validation for each species [Bioanalytics]

posted by janmacek – Czech Republic, 2016-05-11 15:09 (2903 d 21:50 ago) – Posting: # 16293
Views: 2,145

Dear all,

we are planning validation of a bioanalytical method for the determination of a drug candidate in plasma. This method should be used for the analysis of samples from various species (rat, mouse, dog, etc.). The European Guideline states that full validation should be performed for each species and matrix concerned, while the FDA guideline states that partial validation is required for the change of species within matrix.

What is your experience with this topic? Is the approach really different in Europe and US?

With best regards,

Jan

Complete thread:

UA Flag
Activity
 Admin contact
22,990 posts in 4,826 threads, 1,666 registered users;
70 visitors (1 registered, 69 guests [including 6 identified bots]).
Forum time: 12:59 CEST (Europe/Vienna)

If you don’t like something change it;
if you can’t change it, change the way you think about it.    Mary Engelbreit

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5